Yahoo Web Search

Search results

1. meridian.allenpress.com › 725 › 453067Paul Ehrlich | Archives of Pathology & Laboratory Medicine

   meridian.allenpress.com › 725 › 453067

   • Cached

   Jun 1, 2001 · Ehrlich's techniques of fixation and staining of blood films with aniline dyes greatly facilitated the study of blood and bone marrow. Ehrlich distinguished 3 types of granulated white blood cells, as well as normoblasts, megaloblasts, and leukemic cells.

2. ashpublications.org › thehematologist › articlePaul Ehrlich (1854-1915) and the Birth of Molecular Medicine

   ashpublications.org › thehematologist › article

   • Cached

   Oct 20, 2015 · Ehrlich also tried to apply his magic bullet concept to anticancer chemotherapy. However, in his days, the etiology of cancer remained unknown, and no cancer-specific structures (molecules) had been detected.

   • Author: Bernd Groner, Hans-Peter Horny, Fritz Sörgel, Udo Schumacher, Peter Valent

   • Publish Year: 2015

3. www.nature.com › articles › ni0705-639Paul Ehrlich, archives and the history of immunology - Nature

   www.nature.com › articles › ni0705-639

   Jul 1, 2005 · Among the newly acquired materials are about 20 laboratory notebooks, some dating from Ehrlich's 1880s studies using aniline dyes to identify previously unknown types of blood cells and others...

   • Author: Arthur M Silverstein
   • Email: arts@jhmi.edu

   • Publish Year: 2005

4. www.nature.com › articles › nrd1498Paul Ehrlich: Magister Mundi | Nature Reviews Drug Discovery

   www.nature.com › articles › nrd1498

   Sep 1, 2004 · Ehrlich's chemotherapy led directly into antibacterial chemotherapy. Prontosil, discovered in 1935 ( TIMELINE ), is the sulphonamide of chrysoidin, a dyestuff that had been used as a urinary...

   • Author: Jürgen Drews

   • Publish Year: 2004

5. www.tandfonline.com › doi › fullFull article: Paul Ehrlich, a prescient pioneer in the field ...

   www.tandfonline.com › doi › full

   Jan 10, 2014 · The basis of unique chemoreceptors being used to develop more specific agents that not only target particular pathogens but also have no toxic host effect was proposed by Ehrlich. He realized that moving from laboratory studies to clinical implementation was fraught with dangers.

   • Author: Glenn S Tillotson, Stephen H Zinner

   • Publish Year: 2013

6. www.nature.com › articles › nrc2394Paul Ehrlich's magic bullet concept: 100 years of progress

   www.nature.com › articles › nrc2394

   May 12, 2008 · One hundred years ago, Paul Ehrlich, the founder of chemotherapy, received the Nobel Prize for Physiology or Medicine. His postulate of creating 'magic bullets' for use in the fight against human...

7. People also ask

   How did Ehrlich's chemotherapy lead to antibacterial chemotherapy?

   • Ehrlich's chemotherapy led directly into antibacterial chemotherapy. Prontosil, discovered in 1935 (TIMELINE), is the sulphonamide of chrysoidin, a dyestuff that had been used as a urinary disinfectant.

   Paul Ehrlich: Magister Mundi | Nature Reviews Drug Discovery

   www.nature.com/articles/nrd1498

   See all results for this question

   How many'magic bullets' did Ehrlich discover?

   • Among the newly acquired materials are about 20 laboratory notebooks, some dating from Ehrlich's 1880s studies using aniline dyes to identify previously unknown types of blood cells and others appearing to be from his 1905–1910 systematic screening of hundreds of chemical compounds to discover a 'magic bullet' drug to treat syphilis.

   Paul Ehrlich, archives and the history of immunology - Nature

   www.nature.com/articles/ni0705-639

   See all results for this question

   What did Paul Ehrlich say about chemotherapeutics?

   • It is almost a century since Professor Paul Ehrlich of the Royal Institute for Experimental Therapy in Frankfurt (Germany) gave the address in Pathology on Chemotherapeutics: scientific principles, methods and results . Many of the key points of Ehrlich’s treatise set the stage for modern therapeutics in the treatment of infectious diseases.

   Full article: Paul Ehrlich, a prescient pioneer in the field of

   www.tandfonline.com/doi/full/10.1586/eri.12.166

   See all results for this question

   Why did Paul Ehrlich create'magic bullets'?

   • Provided by the Springer Nature SharedIt content-sharing initiative One hundred years ago, Paul Ehrlich received the Nobel Prize for Physiology or Medicine. His idea of creating 'magic bullets' for use in the fight against human diseases has inspired generations of scientists to devise powerful molecular cancer therapeutics.

   Paul Ehrlich's magic bullet concept: 100 years of progress

   www.nature.com/articles/nrc2394

   See all results for this question

   What types of cells did Ehrlich study?

   • Despite his interest in mast cells, Ehrlich was also drawn to other cell types, including lymphocytes and connective tissue cells. Additionally, he worked on diverse microbial cell systems and developed a precursor technique to the Gram staining of bacteria.

   Paul Ehrlich (1854-1915) and the Birth of Molecular Medicine

   ashpublications.org/thehematologist/article/doi/10.1182/hem.V12.6.4513/462786/Paul-Ehrlich-1854-1915-and-the-Birth-of-Molecular

   See all results for this question

   Why is Ehrlich important?

   • Ehrlich became best known as the founder of chemotherapy (Timeline; Box 1), and as a major force in theoretical and practical immunology. However, he also made important contributions to histology, provided the morphological and functional basis for clinical haematology, and greatly enriched medical diagnostics through clinical chemistry.

   Paul Ehrlich: Magister Mundi | Nature Reviews Drug Discovery

   www.nature.com/articles/nrd1498

   See all results for this question

8. www.pei.de › EN › instituteArticles on Paul Ehrlich - Work, Research and Life - Paul ...

   www.pei.de › EN › institute

   • Cached

   Nov 21, 2019 · The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel Prize (Pharmacology, 82, 2008) The Return of Ehrlich's 'Therapia magna sterilisans' and Other Ehrlich Concepts? (Chemotherapy, 50, 2004)